Clinical Trials
20 trialsReplaceCysto
White River Junction Veterans Affairs Medical Center
CaRPET
Washington D.C. Veterans Affairs Medical Center
SNARE
VA Office of Research and Development
CHOMP
VA Office of Research and Development
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
VA Office of Research and Development
COBRA
VA Office of Research and Development
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
VA Office of Research and Development
VA-BAT
VA Office of Research and Development
PROSPYL
VA Greater Los Angeles Healthcare System
VD3PCa
VA Office of Research and Development
PSMA PET Scan and mpMRI for Prostate Cancer Detection
VA Greater Los Angeles Healthcare System
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.
Portland VA Medical Center
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
James J. Peters Veterans Affairs Medical Center
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Portland VA Medical Center
Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
VA Greater Los Angeles Healthcare System
vit D & PCa
VA Office of Research and Development
Calcifidol Therapy in Men With Cancer
VA Office of Research and Development
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
VA Office of Research and Development
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
Department of Veterans Affairs, New Jersey
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
Department of Veterans Affairs, New Jersey